[ad_1]
The Agricultural Research Institute of Uruguay (INIA) has signed an agreement with the Spanish company Innova Life for research aimed at the production of cannabis for medical use. INIA President, José Repetto, said that "Uruguay is at the forefront of the world in regulating the use of cannabis for medical use and is found today in a very advantageous situation with respect to the genetic material capable of foreign investors. "
Repetto said that the activity of his institute will focus on crop badessment and the search for genetic improvements and the development of their agronomic components.
What happened today? We tell you the most important news of the day and what will happen tomorrow when you get up
Monday to Friday afternoon.
The studies will begin after Innova Life obtains the corresponding authorizations from the Cannabis Regulatory and Control Institute (IRCCA), a public body created after the historic approval of the regulation of recreational marijuana production in Uruguay. 2013
"In two years, we can have results. If we badyze the global situation, growing medical cannabis, investor interest in coming to Uruguay and starting to work with registered genetics at the Seed Institute, it will save time and speed. we will have a very strong demand, "said Repetto.
On February 11, an official call for tenders was opened which allowed Up to five new companies they join the two already installed to produce marijuana for recreational purposes. Accepted signatures They must produce 2,000 kg of cannabis a year on land owned by the Uruguayan state.
This occurred after state data indicated that the number of registered consumers to buy legal marijuana in Uruguayan pharmacies it has been multiplied by more than six since the start of the public sale in July 2017.
In 2013, Uruguay approved an unprecedented law allowing domestic cultivation of marijuana with up to six plants per household; Cooperative culture in clubs counting up to 99 plants per badociation and the purchase of marijuana produced by private state-controlled companies through pharmacies in the country, to reason of 40 grams per month for registered users before the Ircca.
.
[ad_2]
Source link